Literature DB >> 19188337

Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation.

Ye Li1, Yue Cui, Steven N Hart, Curtis D Klaassen, Xiao-bo Zhong.   

Abstract

Human cytochrome P450 3A (CYP3A) members are major drug-metabolizing enzymes in the liver. Two genes, CYP3A4 and CYP3A7, exhibit a developmental switch in gene expression during liver maturation. CYP3A4 is mainly expressed in adults, whereas CYP3A7 is dominantly expressed during the fetal and neonatal stages. Their ontogenic expression results in developmentally related changes in the capacity to metabolize endogenous and exogenous compounds. Thus, it is desirable to understand the mechanisms controlling the developmental switch. Mice also exhibit a developmental switch between Cyp3a16 (neonatal isoform) and Cyp3a11 (adult isoform) and may serve as a model to study the mechanisms controlling the developmental switch. Because the epigenetic code (e.g., DNA methylation and histone modifications) is implicated in regulating gene expression and cellular differentiation during development, the current study determined the status of DNA methylation, histone-3-lysine-4 dimethylation (H3K4me2) and histone-3-lysine-27 trimethylation (H3K27me3) around the mouse Cyp3a locus at various developmental ages from prenatal, through neonatal, to young adult. DNA was not hypermethylated in the Cyp3a locus at any age. However, increases in Cyp3a16 expression in neonatal livers and Cyp3a11 in adult livers were associated with increases of H3K4me2. Suppression of Cyp3a16 expression in adult livers coincided with decreases of H3K4me2 and increases of H3K27me3 around Cyp3a16. In conclusion, histone modifications of H3K4me2 and H3K27me3 are dynamically changed in a locus-specific manner along the Cyp3a locus. Developmental switch between Cyp3a11 and Cyp3a16 gene expression seems to be due to dynamic changes of histone modifications during postnatal liver maturation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188337      PMCID: PMC2672803          DOI: 10.1124/mol.108.052993

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  43 in total

Review 1.  DNA methylation patterns and epigenetic memory.

Authors:  Adrian Bird
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

2.  Isolation of a promoter region in mouse cytochrome P450 3A (Cyp3A16) gene and its transcriptional control.

Authors:  S Itoh; Y Abe; A Kubo; M Okuda; M Shimoji; K Nakayama; T Kamataki
Journal:  Biochim Biophys Acta       Date:  1997-02-07

3.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.

Authors:  X Nan; H H Ng; C A Johnson; C D Laherty; B M Turner; R N Eisenman; A Bird
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

4.  A novel female-specific member of the CYP3A gene subfamily in the mouse liver.

Authors:  T Sakuma; M Takai; Y Endo; M Kuroiwa; A Ohara; K Jarukamjorn; R Honma; N Nemoto
Journal:  Arch Biochem Biophys       Date:  2000-05-01       Impact factor: 4.013

5.  Studies on transcriptional regulation of Cyp3a16 gene in mouse livers by application of direct DNA injection method.

Authors:  K Nakayama; Y Sudo; Y Sasaki; H Iwata; M Takahashi; T Kamataki
Journal:  Biochem Biophys Res Commun       Date:  2001-10-05       Impact factor: 3.575

6.  Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth.

Authors:  D Lacroix; M Sonnier; A Moncion; G Cheron; T Cresteil
Journal:  Eur J Biochem       Date:  1997-07-15

7.  Developmental expression of the major human hepatic CYP3A enzymes.

Authors:  Jeffrey C Stevens; Ronald N Hines; Chungang Gu; Sevasti B Koukouritaki; Jason R Manro; Peter J Tandler; Matthew J Zaya
Journal:  J Pharmacol Exp Ther       Date:  2003-09-15       Impact factor: 4.030

8.  Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.

Authors:  J Andrew Williams; Barbara J Ring; Varon E Cantrell; David R Jones; James Eckstein; Kenneth Ruterbories; Mitchell A Hamman; Stephen D Hall; Steven A Wrighton
Journal:  Drug Metab Dispos       Date:  2002-08       Impact factor: 3.922

9.  Three patterns of cytochrome P450 gene expression during liver maturation in mice.

Authors:  Steven N Hart; Yue Cui; Curtis D Klaassen; Xiao-bo Zhong
Journal:  Drug Metab Dispos       Date:  2008-10-09       Impact factor: 3.922

10.  Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver.

Authors:  J D Schuetz; D L Beach; P S Guzelian
Journal:  Pharmacogenetics       Date:  1994-02
View more
  29 in total

Review 1.  Interindividual Variability in Cytochrome P450-Mediated Drug Metabolism.

Authors:  Timothy S Tracy; Amarjit S Chaudhry; Bhagwat Prasad; Kenneth E Thummel; Erin G Schuetz; Xiao-Bo Zhong; Yun-Chen Tien; Hyunyoung Jeong; Xian Pan; Laura M Shireman; Jessica Tay-Sontheimer; Yvonne S Lin
Journal:  Drug Metab Dispos       Date:  2015-12-17       Impact factor: 3.922

Review 2.  Linking the Epigenome with Exposure Effects and Susceptibility: The Epigenetic Seed and Soil Model.

Authors:  Emma C Bowers; Shaun D McCullough
Journal:  Toxicol Sci       Date:  2016-10-20       Impact factor: 4.849

Review 3.  Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.

Authors:  Volker M Lauschke; Yitian Zhou; Magnus Ingelman-Sundberg
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

4.  Ontogeny of novel cytochrome P450 gene isoforms during postnatal liver maturation in mice.

Authors:  Julia Yue Cui; Helen J Renaud; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2012-03-23       Impact factor: 3.922

5.  Role of Chromatin Structural Changes in Regulating Human CYP3A Ontogeny.

Authors:  Nicholas L Giebel; Jeffrey D Shadley; D Gail McCarver; Kenneth Dorko; Roberto Gramignoli; Stephen C Strom; Ke Yan; Pippa M Simpson; Ronald N Hines
Journal:  Drug Metab Dispos       Date:  2016-02-26       Impact factor: 3.922

Review 6.  Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.

Authors:  Haixing Li; Jed N Lampe
Journal:  Arch Biochem Biophys       Date:  2019-08-22       Impact factor: 4.013

Review 7.  Molecular targets of epigenetic regulation and effectors of environmental influences.

Authors:  Supratim Choudhuri; Yue Cui; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2010-04-08       Impact factor: 4.219

8.  RNA sequencing reveals dynamic changes of mRNA abundance of cytochromes P450 and their alternative transcripts during mouse liver development.

Authors:  Lai Peng; Byunggil Yoo; Sumedha S Gunewardena; Hong Lu; Curtis D Klaassen; Xiao-Bo Zhong
Journal:  Drug Metab Dispos       Date:  2012-03-20       Impact factor: 3.922

9.  Effect of the active ingredient of Kaempferia parviflora, 5,7-dimethoxyflavone, on the pharmacokinetics of midazolam.

Authors:  Wataru Ochiai; Hiroko Kobayashi; Satoshi Kitaoka; Mayumi Kashiwada; Yuya Koyama; Saho Nakaishi; Tomomi Nagai; Masaki Aburada; Kiyoshi Sugiyama
Journal:  J Nat Med       Date:  2018-03-17       Impact factor: 2.343

10.  Genetic associations with reflexive visual attention in infancy and childhood.

Authors:  Rebecca A Lundwall; James L Dannemiller; H Hill Goldsmith
Journal:  Dev Sci       Date:  2015-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.